Hepatitis C, ChronicNCT01457755
Gilead Sustained Virologic Response (SVR) Registry
An observational study of Hepatitis C, Chronic, run by Gilead Sciences at 325 sites in 17 countries.
Trial summary
This Registry is designed to provide long term clinical and virologic follow up in participants who have achieved sustained virologic response (SVR) while participating in a previous Gilead sponsored hepatitis C virus (HCV) study. This long term follow up study is observational and no treatment is provided for HCV. Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Hepatitis C, Chronic
- How many people
- 6,625 participants
- Where
- 325 sitesin 17 countries
- Study dates
- 13 Apr 2012to 8 Jan 2018
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Study population: Participants who have achieved sustained virologic response (SVR) while participating in a previous Gilead sponsored HCV study.
Who may be able to join
- Have previously participated in a Gilead-sponsored hepatitis C study and received at least one Gilead oral antiviral agent (OAV)
- Have achieved SVR in a Gilead-sponsored study, as defined in the original treatment protocol
- Provide written, informed consent
- Be willing and able to comply with the visit schedule and protocol-mandated procedures
Who cannot join
- Individuals planning to start a new course of hepatitis C therapy including any investigational drug or device during the course of the follow-up Registry
- History of clinically significant illness or any other major medical disorder that may interfere with follow up, assessments, or compliance with the protocol
- Note: Other protocol defined Inclusion/Exclusion criteria may apply.
Trial locations and contacts
325 sites in 17 countries.
325 sites in 17 countries
United States162 sites
University of New Mexico
Albuquerque, New Mexico
Lehigh Valley Health Network, Network Office of Research and Innovation
Allentown, Pennsylvania, 18102
Advanced Clinical Research Institute, LLC
Anaheim, California, 92801
University of Michigan Medical Center
Ann Arbor, Michigan
Metropolitan Research
Annandale, Virginia
The North Texas Clinical Research Institute
Arlington, Texas, 76012
Asheville Gastroenterology Associates, P.A.
Asheville, North Carolina, 28801
Atlanta Gastroenterology Associates
Atlanta, Georgia, 30308
The Emory Clinic
Atlanta, Georgia, 30308
Digestive Healthcare of Georgia
Atlanta, Georgia, 30309
Atlanta Medical Center
Atlanta, Georgia, 30312
University of Colorado Hospital
Aurora, Colorado, 80045
Central Texas Clinical Research, LLC
Austin, Texas
Franco Felizarta, MD
Bakersfield, California, 93301
Mercy Medical Center
Baltimore, Maryland, 21202
Digestive Disease Associates, PA
Baltimore, Maryland, 21229
Delta Research Partners, LLC
Bastrop, Louisiana, 71220
Medical Development Centers, LLC
Baton Rouge, Louisiana, 70808
Gastroenterology Associates, LLC
Baton Rouge, Louisiana, 70809
Comprehensive Clinical Research
Berlin, New Jersey, 08009
Binghamton Gastroenterology Associates, PC
Binghamton, New York
Birmingham Gastroenterology Associates
Birmingham, Alabama, 35209
University of Alabama at Birmingham
Birmingham, Alabama, 35233
Massachusetts General Hospital
Boston, Massachusetts, 02114
Beth Israel Deaconess Medical Center
Boston, Massachusetts, 02115
Community Research Initiative of New England
Boston, Massachusetts
Graves-Gilbert Clinic
Bowling Green, Kentucky, 42101
Bach and Godofsky Infectious Diseases
Bradenton, Florida, 34209
Lahey Clinic Medical Center
Burlington, Massachusetts, 01805
University of North Carolina at Chapel Hill
Chapel Hill, North Carolina, 27599
University of North Carolina
Chapel Hill, North Carolina
Carolinas Medical Center
Charlotte, North Carolina
Ruth M. Rothstein CORE Center
Chicago, Illinois, 60612
University of Chicago
Chicago, Illinois, 60637
Northwestern Memorial Hospital
Chicago, Illinois
University of Cincinnati
Cincinnati, Ohio, 45267-0595
University of Maryland
College Park, Maryland, 20742
University of Miami - Dept of Neurology
Coral Gables, Florida, 33146
Southern California Liver Centers
Coronado, California, 92118
West Coast Clinical Trials, LLC
Costa Mesa, California, 92626
UT Southwestern Medical Center
Dallas, Texas, 75235
Baylor Endocrine Center
Dallas, Texas, 75246
UT Southwestern Medical Center at Dallas
Dallas, Texas, 75390
Methodist Dallas Medical Center
Dallas, Texas
Southwest Infectious Disease Clinical Research, Inc
Dallas, Texas
Dekalb Gastroenterology Associates, LLC
Decatur, Georgia, 30033-6134
Infectious Disease Specialists of Atlanta, PC
Decatur, Georgia, 30033
Henry Ford Health System
Detroit, Michigan, 48202
Digestive Health Specialists of the Southeast, PA
Dothan, Alabama, 35305
Duke University Medical Center
Durham, North Carolina, 27710
South Denver Gastroenterology
Englewood, Colorado, 80113
Inova Fairfax Hospital Center for Liver Diseases
Falls Church, Virginia, 22042
Cumberland Research Associates, LLC
Fayetteville, North Carolina, 28304
University of Florida Hepatology Research at CTRB
Gainesville, Florida, 32610
Memphis Gastroenterology Group
Germantown, Tennessee, 38138
Gastro One
Germantown, Tennessee
Gastroenterology Center of Connecticut
Hamden, Connecticut, 06518
ID Care, Inc.
Hillsborough, New Jersey, 08844
The Queen's Medical Center-Liver Center
Honolulu, Hawaii, 96813
Therapeutic Concepts, PA
Houston, Texas, 77004
Kelsey Research Foundation
Houston, Texas, 77005
Research Specialists of Texas
Houston, Texas, 77030
St. Luke's Health Baylor College of Medicine Medical Center
Houston, Texas, 77030
University of Texas Health Science Center at Houston
Houston, Texas, 77030
Baylor College of Medicine
Houston, Texas
CHI Health Reseach Center
Houston, Texas
Indianapolis Gastroenterology Research Foundation
Indianapolis, Indiana, 46237
Indiana University School of Medicine
Indianapolis, Indiana
Borland-Groover Clinic
Jacksonville, Florida, 32207
University of Kansas Medical Center
Kansas City, Kansas
Kansas City Research Institute, LLC
Kansas City, Missouri
The Kansas City Free Health Clinic
Kansas City, Missouri
Scripps Clinic Medical Group
La Jolla, California, 92037
eStudySite
La Mesa, California, 91942
Regional Gastroenterology Associates of Lancaster, Ltd.
Lancaster, Pennsylvania, 17604
Gastroenterology Consultants PLC
Live Oak, Texas
Long Beach VA Medical Center
Long Beach, California, 90822
Ruane Clinical Research Group
Los Angeles, California, 90036
National Research Institute
Los Angeles, California, 90057
Anthony Mills MD, Inc
Los Angeles, California
Cedars-Sinai Medical Center
Los Angeles, California
Kaiser Permanente
Los Angeles, California
Veterans Administration Wadsworth Medical Center
Los Angeles, California
Johns Hopkins University
Lutherville, Maryland, 21093
University of Wisconsin Hospital and Clinics
Madison, Wisconsin
Northwell Health
Manhasset, New York, 11030
Northwell Health
Manhasset, New York
Gastrointestinal Specialists of Georgia, PC
Marietta, Georgia, 30060
Schleinitz Research and Gastroenterology LLC
Medford, Oregon, 97504
University of Miami
Miami, Florida, 33136
Atlantic Research Affiliates, LLC
Morristown, New Jersey
Intermountain Medical Center
Murray, Utah, 84107
The Frist Clinic
Nashville, Tennessee, 37203
Nashville Medical Research Institute
Nashville, Tennessee, 37205
Quality Medical Research, PLLC
Nashville, Tennessee
Yale University
New Haven, Connecticut, 06520
Advanced Research Institute
New Port Richey, Florida, 34653
Concorde Medical Group PLLC
New York, New York, 10016
Weill Cornell Medical College of Cornell Univeristy
New York, New York, 10021
St. Luke's Roosevelt Hospital
New York, New York, 10025
Columbia Presbyterian Hospital, Columbia University
New York, New York, 10032
Icahn School of Medicine at Mount Sinai
New York, New York
Saint Michael's Medical Center
Newark, New Jersey, 07102
Liver Institute of Virginia
Newport News, Virginia
Digestive and Liver Disease Specialists
Norfolk, Virginia, 23502
eStudySite
Oceanside, California, 92056
Orlando Immunology Center
Orlando, Florida, 32803-1851
Internal Medicine Specialists
Orlando, Florida, 32806
Orlando Clinical Research Center
Orlando, Florida, 32809
Stanford University
Palo Alto, California, 94304
Huntington Medical Research Institutes
Pasadena, California
University of Pennsylvania Hospital
Philadelphia, Pennsylvania, 19104
Philadelphia FIGHT
Philadelphia, Pennsylvania, 19107
University of Pennsylvania School of Medicine
Philadelphia, Pennsylvania
Mayo Clinic
Phoenix, Arizona
UPMC Center For Liver Diseases
Pittsburgh, Pennsylvania, 15213
Veterans Affairs Pittsburgh Healthcare System
Pittsburgh, Pennsylvania
Oregon Health & Science University
Portland, Oregon, 97239
University Gastroenterology
Providence, Rhode Island, 02905
The Miriam Hospital
Providence, Rhode Island
Inland Empire Liver Foundation
Rialto, California
Virginia Commonwealth University Medical Center
Richmond, Virginia
Mayo Clinic
Rochester, Minnesota
University of Rochester
Rochester, New York
University of California Davis Medical Center
Sacramento, California, 95187
UC Davis Medical Center
Sacramento, California, 95817
Minnesota Gastroenterology
Saint Paul, Minnesota, 55114
University of Utah
Salt Lake City, Utah, 84143
PRA Health Sciences
Salt Lake City, Utah
The Texas Liver Institute
San Antonio, Texas
University of California at San Diego
San Diego, California, 92103
Research and Education, Inc.
San Diego, California, 92115
Medical Associates Research Group, Inc.
San Diego, California, 92123
Kaiser Permanente
San Diego, California, 92154
University of California San Diego
San Diego, California, 92161
California Pacific Medical Center
San Francisco, California, 94115
Quest Clinical Research
San Francisco, California, 94115
Kaiser Permanente Center
San Francisco, California
Silicon Valley Research Institute
San Jose, California
Southwest C.A.R.E. Center
Santa Fe, New Mexico, 87505
Virginia Mason Medical Center
Seattle, Washington, 98101
Harborview Medical Center
Seattle, Washington
The Research Institute
Springfield, Massachusetts, 01105
Washington University School of Medicine
St Louis, Missouri, 63108
Saint Louis University
St Louis, Missouri
Carolinas Center for Liver Disease
Statesville, North Carolina
Saint Joseph's Hospital
Tampa, Florida
Tampa General Hospital
Tampa, Florida
Bronx Veteran's Affairs Medical Center
The Bronx, New York, 10468
Los Angeles BioMedical Research Institute at Harbor-UCLA Medical Center
Torrance, California, 90502
The University of Arizona
Tucson, Arizona, 85724
Options Health Research LLC
Tulsa, Oklahoma, 74104
Digestive Health Specialists
Tupelo, Mississippi, 38801
The Gastroenterology Group of South Jersey
Vineland, New Jersey, 08360
Georgetown University Medical Center
Washington D.C., District of Columbia, 20007
Whitman-Walker Health
Washington D.C., District of Columbia, 20009
Capital Medical Associates, P.C.
Washington D.C., District of Columbia, 20036
South Florida Center of Gastroenterology, P.A.
Wellington, Florida, 33414
Digestive Health Specialists, PA
Winston-Salem, North Carolina, 27103
Partners in Internal Medicine, PC
Worcester, Massachusetts, 01608
University of Massachusetts
Worcester, Massachusetts
Westchester Digestive Disease Group
Yonkers, New York, 10701
Australia25 sites
Royal Adelaide Hospital
Adelaide, South Australia, 5000
Flinders University
Bedford Park, South Australia, 5042
Royal Prince Alfred Hospital
Camperdown, New South Wales, 2050
Canberra Specialist Centre
Canberra, Australian Capital Territory
Monash Medical Centre
Clayton, Victoria, 3168
Concord Repatriation General Hospital
Concord, New South Wales, 2137
East Sydney Doctors
Darlinghurst, New South Wales
Holdsworth House Medical Practice
Darlinghurst, New South Wales
St Vincent's Public Hospital Sydney
Darlinghurst, New South Wales
St. Vincent's Hospital Melbourne
Fitzroy, Victoria, 3065
Footscray Hospital
Footscray, Victoria, 3011
Fremantle Hospital
Fremantle, Western Australia
Greenslopes Private Hospital
Greenslopes, 4102
Austin Health
Heidelberg, Victoria, 3084
Royal Brisbane & Women's Hospital
Herston, QLD 4029
St George Hospital
Kogarah, New South Wales, 2217
Liverpool Hospital
Liverpool, New South Wales, 2170
Alfred Hospital
Melbourne, Victoria, 3004
Alfred Hospital
Melbourne, Victoria
Fiona Stanley Hospital
Murdoch, Western Australia
Sir Charles Gairdner Hospital
Nedlands, 6009
The Royal Melbourne Hospital
Parkville, Victoria, 3050
Royal Perth Hospital
Perth, 6001
Westmead Hospital
Westmead, New South Wales, 2145
Princess Alexandra Hospital
Woolloongabba, 4102
France25 sites
Centre Hospitalier Universitaire de Grenoble
Cedex 9, Auvergne-Rhône-Alpes, 38043
Centre Hospitalier Universitaire de Clermont-Ferrand
Clermont-Ferrand, Auvergne
Hopital Beaujon
Clichy, 92110
Hôpital Henri Mondor
Créteil, Île-de-France Region
Hôpital Claude Huriez- Service d'Hépato-Gastroentérologie
Lille, Hauts-de-France
Centre Hospitalier Universitaire (CHU) De Limoges - Hopital Dupuytren
Limoges, Limousin
Hôpital-Saint Joseph, Service D'Hépato-Gastroentérologie
Marseille, Provence-Alpes-Côte d'Azur Region
Hopital Saint-Eloi
Montpellier, 34295
Hôpital de I´Archet 2
Nice, Provence-Alpes-Côte d'Azur Region
CHU de Nice - Hôpital l'Archet
Nice, 06202
Hôpital Saint Louis
Paris, 75010
Hôpital la Pitié Salpêtrière
Paris, 75013
Hôpital Cochin
Paris, 75679
Hôpital Saint-Antoine
Paris, Île-de-France Region, 75012
CHU Pitié-Salpêtrière
Paris, Île-de-France Region, 75651
Hôpital Bichat-Claude Bernard
Paris, Île-de-France Region, 75877
Hôpital Saint-Antoine
Paris, Île-de-France Region
Hôpital Tenon
Paris, Île-de-France Region
Centre Hospitalier Universitaire Bordeaux Hôpital Haut-Lévêque
Pessac, 33604
Hopital Pontchaillou
Rennes, 35033
C.H.U. Strasbourg
Strasbourg, 67091
CIC Hopital Purpan
Toulouse, Midi-pyrenees, 31059
CIC Hopital Purpan
Toulouse, Midi-pyrenees
Hopitaux De Brabois
Vandœuvre-lès-Nancy, Limousin, Lorraine
Hôpital Paul Brousse
Villejuif, Île-de-France Region
Germany24 sites
Leber- and Studienzentrum am Checkpoint
Berlin, 10969
EPIMED GmbH
Berlin, 12157
Charité Universitätsmedizin Berlin
Berlin, 13353
Zentrum für Infektiologie Berlin Prenzlauer Berg GmbH
Berlin
Universitäts Bonn
Bonn, 53105
Klinikum der Universität zu Köln
Cologne, North Rhine-Westphalia
Medizinisches Versorgungszentrum
Düsseldorf, North Rhine-Westphalia
Universitätsklinikum Düsseldorf
Düsseldorf, North Rhine-Westphalia
Universitätsklinikum Essen
Essen, North Rhine-Westphalia
Universitätsklinikum Frankfurt
Frankfurt
Infektiologikum Frankfurt
Frankfurt am Main, Hesse
Universitätsklinikum Frankfurt
Frankfurt am Main, Hesse
Albert-Ludwigs-Universität
Freiburg im Breisgau, Baden-Wurttemberg
PraxisZentrum für Gastroenterologie und Endokrinologie
Freiburg im Breisgau, Baden-Wurttemberg
Asklepios Klinik St. Georg
Hamburg, 20099
Universitatsklinikum Hamburg-Eppendorf
Hamburg, 20246
Medizinische Hochschule Hannover
Hanover, 30625
Medizinische Universitätsklinik IV (Krehl Klinik) Abt. Gastroenterologie und Infektionskrankhen
Heidelberg, Baden-Wurttemberg
Gastroenterologische Gemeinschaftspraxis
Herne, North Rhine-Westphalia
Gastroenterologische Gemeinschaftspraxis Kiel Preetzer
Kiel, 24146
University of Leipzig
Leipzig, 04103
Mainz University
Mainz
Medizinische Klinik und Poliklinik III
München, Bavaria
Centrum für Interdisziplinäre Medizin
Münster, North Rhine-Westphalia
Italy15 sites
Azienda Ospedaliera Papa Giovanni XXIII
Bergamo, 24128
Azienda Ospedaliera di Bologna - Policlinico S. Orsola Malpighi
Bologna, 40138
Azienda Ospedaliera S. Orsola - Malpighi
Bologna
Ente Ospedaliero Ospedali Galliera di Genova
Genova
Ospedale San Raffaele-IRCCS, Centro San Luigi - San Raffaele Turro, Unità Operativa di Malattie Infettive
Milan, 20127
Azienda Ospedaliera - Polo Universitario Luigi Saco
Milan, 20157
Azienda Ospedaliera Ospedale Niguarda Ca' Granda
Milan
Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico
Milan
Azienda Ospedaliera Padova, U.O.C. Cardiologia
Padova
Azienda Ospedaliera-universitaria Policlinico P. Giaccone
Palermo, 90127
Azienda Ospedaliero Universitaria di Parma
Parma
Instituto Nationale Per Le Malattie Infettive "Lazzaro Spallanzani"
Roma, 00149
Fondazione Policlinico Tor Vergata
Roma
Ospedale Casa Sollievo della Sofferenza
San Giovanni Rotondo, Foggia
Azienda Ospedaliera Città della Salute e della Scienza di Torino
Torino
United Kingdom14 sites
University of Birmingham and Queen Elizabeth Hospital Birmingham
Birmingham, England
Bristol Royal Infirmary
Bristol, England
St George Hospital
London, England, SW17 0QT
Chelsea and Westminster Hospital NHS Foundation Trust
London, England
Guy's and Saint Thomas NHS Foundation Trust
London, England
Imperial College Healthcare NHS Trust
London, England
King's College Hospital
London, England
Royal Free London NHS Foundation Trust
London, England
North Manchester General Hospital
Manchester, England
Nottingham University Hospitals NHS Trust
Nottingham, England
John Radcliffe Hospital
Oxford, England, OX3 9DU
Derriford Hospital
Plymouth, England
Queen Alexandra Hospital
Portsmouth, England, PO6 3LY
Southampton University Hospitals NHS Trust, Southampton General Hospital
Southampton, England
Spain13 sites
Hospital Clinic I Provincial de Barcelona
Barcelona, 08036
Hospital Clinic I Provincial de Barcelona
Barcelona
Hospital General Universitario Gregorio Marañon
Madrid, 28007
Hospital Universitario 12 de Octubre
Madrid, 28041
Hospital Universitario La Paz
Madrid, 28046
Hospital Ramón y Cajal
Madrid
Hospital Universitario La Paz
Madrid
Hospital Puerta de Hierro Majadahonda
Majadahonda, Madrid
Hospital Clínico Universitario Virgen de la Victoria
Málaga, Malaga
Hospital Universitario Marques de Valdecilla
Santander
Hospital Universitario Nuestra Señora de Valme
Seville, 41014
Hospital Universitario Nuestra Señora de Valme
Seville
Hospital General Universitario de Valencia
Valencia
Canada12 sites
University of Calgary Liver Unit
Calgary, Alberta, T2N 4Z6
University of Alberta Hospital
Edmonton, Alberta, T6G 2CB
Centre Hospitalier de L'Universite de Montreal (CHUM)
Montreal, Quebec, H1T 2M4
Ottawa General Hospital
Ottawa, Ontario
Toronto General Hospital
Toronto, Ontario, M5G 2N2
Toronto Western Hospital
Toronto, Ontario, M5T 2S8
Toronto Liver Centre
Toronto, Ontario, M6H 3M1
Liver and Intestinal Research Center
Vancouver, British Columbia, V5Z 1H2
GIRI GI Research Institute
Vancouver, British Columbia, V6Z 2K5
Gordon and Leslie Diamond Health Care Centre
Vancouver, British Columbia
Vancouver Infectious Disease Research and Care Centre
Vancouver, British Columbia
University of Manitoba
Winnipeg, Manitoba, R3E 3P4
New Zealand7 sites
Christchurch Hospital
Christchurch, 8011
Dunedin Hospital
Dunedin
Auckland Clinical Studies Limited
Grafton, Auckland, 1010
Auckland City Hospital
Grafton, Auckland
Urosurgery
Hamilton
Wellington Hospital
Newtown, WGN, 6021
Bay of Plenty Clinical School
Tauranga, Bay of Plenty
Poland6 sites
Wojewódzki Szpital Specjalistyczny im. Kazimierza Dluskiego w Bialymstoku
Bialystok, Podlaskie Voivodeship
Szpital Specjalistyczny w Chorzowie
Chorzów, Silesian Voivodeship
Spzoz Wojewodzki Specjalistyczny Szpital im. W. Bieganskiego W Lodzi
Lodz, 91-347
ID Clinic Arkadiusz Pisula
Mysłowice, Silesian Voivodeship
SP ZOZ Wojewódzki Szpital Zakazny
Warsaw, Masovian Voivodeship
Centrum Badan Klinicznych
Wroclaw, Lower Silesian Voivodeship
Belgium4 sites
Ziekenhuis Netwerk Antwerpen Campus Stuivenberg
Antwerp
Cliniques Universitaires Saint Luc
Brussels
Université Libre de Bruxelles Hôpital Erasme
Brussels
AZ Groeninge Kortrijk
Kortrijk
Netherlands4 sites
Academisch Medisch Centrum
Amsterdam, North Holland
Leiden Universitair Medisch Centrum
Leiden, South Holland
Universitair Medisch Centrum Sint Radboud
Nijmegen
Erasmus Medisch Centrum
Rotterdam, South Holland
Sweden4 sites
Sahlgrenska Universitetssjukhuset, Östra Sjukhus
Gothenburg, 41685
Skånes Universitetssjukhus i Lund
Lund
Skånes Universitetssjukhus,
Malmö
Karolinska University Hospital Huddinge
Stockholm
Austria3 sites
Medizinische Universität Graz
Graz, Styria
Medizinische Universität Wien
Vienna, State of Vienna
Wilhelminenspital der Stadt Wien
Vienna, State of Vienna
Czechia3 sites
Slezska nemocnice v Opave, Infekcni oddeleni
Opava, 746 01
Klin med, s.r.o.
Prague, 169 02
Remedis, s.r.o.
Prague, Praha 4
Estonia2 sites
West Tallinn Central Hospital
Talinn
Tartu University Hospital
Tartu
Puerto Rico2 sites
Clinical Research Puerto Rico
San Juan, PR
Fundacion De Investigacion De Diego
San Juan, 927
About this study
Official title: A Long Term Follow-up Registry for Subjects Who Achieve a Sustained Virologic Response to Treatment in Gilead-Sponsored Trials in Subjects With Chronic Hepatitis C Infection
This Registry is designed to provide long term clinical and virologic follow up in participants who have achieved sustained virologic response (SVR) while participating in a previous Gilead sponsored hepatitis C virus (HCV) study. This long term follow up study is observational and no treatment is provided for HCV.
- Conditions
- Hepatitis C, Chronic
- Keywords
- Hepatitis C, HCV, Sustained Virologic Response, Direct Acting Antiviral, Combination Therapy, Tegobuvir, Registry, HCV RNA, Treatment experienced, Treatment naive, GS 9451, GS 5885, GS 7977, GS 5816, Sofosbuvir, Sovaldi™, SOF, Ledipasvir, LDV
- Medical subject headings
- Hepatitis C, Chronic, Hepatitis C
What is being measured
The primary outcome is the main question the study is designed to answer.
Proportion of participants maintaining SVR at Week 144 by treatment regimen
Measured: Week 144
Secondary outcomes (5)
Proportion of participants with detectable HCV RNA due to reemergence of preexisting virus through Week 144 by treatment regimen
Measured: Up to 144 weeks
Proportion of participants with detectable HCV resistance mutations through Week 144 by treatment regimen
Measured: Up to 144 weeks
Proportion of participants with detectable HCV RNA due to reinfection through Week 144 by treatment regimen
Measured: Up to 144 weeks
Liver disease progression
Liver disease progression is a composite endpoint measured by laboratory parameters (alanine aminotransferase (ALT), aspartate aminotransferase (AST), bilirubin, albumin, platelets, prothrombin time (PT) and α-fetoprotein) and observed or reported clinical signs and symptoms.
Measured: Up to 144 weeks
Proportion of participants who develop hepatocellular carcinoma (HCC) through Week 144 by treatment regimen
Measured: Up to 144 weeks
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted24 Oct 2011 (estimated)
- Study start13 Apr 2012
- Primary completion28 Mar 2017
- Study completion8 Jan 2018
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (1)Papers the sponsor has linked to this study.
- Other trials for Hepatitis C, ChronicStudies of the same condition, open and under way.
- More trials run by Gilead SciencesThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 6,625 participants (actual)
Sponsor and investigators
- Lead sponsor
- Gilead Sciences
- Sponsor type
- Industry (pharma, biotech, devices)
- Responsible party
- Sponsor
- Investigators
- Gilead Study Director, Study director, Gilead Sciences
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT01457755
- Sponsor's protocol ID
- GS-US-248-0122
- Other IDs
- 2011-000945-19
- Status last verified
- Aug 2018
- First submitted
- 4 Oct 2011
- Last updated
- 31 Aug 2018
- Results posted
- No
- Data monitoring committee
- No
Publications
Younossi ZM, Stepanova M, Racila A, Afendy A, Lawitz EJ, Schwabe C, Ruane PJ, Lalezari J, Reddy KR, Jacobson IM, Muir AJ, Gaggar A, Myers RP, Younossi I, Nader F. Long-term Benefits of Sustained Virologic Response for Patient-Reported Outcomes in Patients With Chronic Hepatitis C Virus Infection. Clin Gastroenterol Hepatol. 2020 Feb;18(2):468-476.e11. doi: 10.1016/j.cgh.2019.07.047. Epub 2019 Jul 31.
PubMed 31376493
Study at a glance
From the registry record, last updated by the sponsor on 31 Aug 2018. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- A Long Term Follow-up Registry for Subjects Who Achieve a Sustained Virologic Response to Treatment in Gilead-Sponsored Trials in Subjects With Chronic Hepatitis C Infection
- ClinicalTrials.gov ID
- NCT01457755
- Acronym / sponsor ID
- GS-US-248-0122
- Conditions
- Hepatitis C, Chronic
- Keywords
- Hepatitis C, HCV, Sustained Virologic Response, Direct Acting Antiviral, Combination Therapy, Tegobuvir, Registry, HCV RNA
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 6,625 participants (actual)
- Lead sponsor
- Gilead SciencesIndustry (pharma, biotech, devices)
- Study start
- 13 Apr 2012 (actual)
- Primary completion
- 28 Mar 2017 (actual)
- Study completion
- 8 Jan 2018 (actual)
- First posted
- 24 Oct 2011 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This Registry is designed to provide long term clinical and virologic follow up in participants who have achieved sustained virologic response (SVR) while participating in a previous Gilead sponsored hepatitis C virus (HCV) study. This long term follow up study is observational and no treatment is provided for HCV.
Study design
- Observational model
- Cohort
- Time perspective
- Prospective
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
- Study population
- Participants who have achieved sustained virologic response (SVR) while participating in a previous Gilead sponsored HCV study.
Key inclusion criteria (4 listed)
- Have previously participated in a Gilead-sponsored hepatitis C study and received at least one Gilead oral antiviral agent (OAV)
- Have achieved SVR in a Gilead-sponsored study, as defined in the original treatment protocol
- Provide written, informed consent
- Be willing and able to comply with the visit schedule and protocol-mandated procedures
Key exclusion criteria (3 listed)
- Individuals planning to start a new course of hepatitis C therapy including any investigational drug or device during the course of the follow-up Registry
- History of clinically significant illness or any other major medical disorder that may interfere with follow up, assessments, or compliance with the protocol
- Note: Other protocol defined Inclusion/Exclusion criteria may apply.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Proportion of participants maintaining SVR at Week 144 by treatment regimen
Time frame: Week 144
5 secondary outcomes
Proportion of participants with detectable HCV RNA due to reemergence of preexisting virus through Week 144 by treatment regimen
Time frame: Up to 144 weeks
Proportion of participants with detectable HCV resistance mutations through Week 144 by treatment regimen
Time frame: Up to 144 weeks
Proportion of participants with detectable HCV RNA due to reinfection through Week 144 by treatment regimen
Time frame: Up to 144 weeks
Liver disease progression
Time frame: Up to 144 weeks
Proportion of participants who develop hepatocellular carcinoma (HCC) through Week 144 by treatment regimen
Time frame: Up to 144 weeks
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 31 Aug 2018.
- Derived from this study: PubMed 31376493Younossi ZM, Stepanova M, Racila A, Afendy A, Lawitz EJ, Schwabe C, Ruane PJ, Lalezari J, Reddy KR, Jacobson IM, Muir AJ, Gaggar A, Myers RP, Younossi I, Nader F. Long-term Benefits of Sustained Virologic Response for Patient-Reported Outcomes in Patients With Chronic Hepatitis C Virus Infection. Clin Gastroenterol Hepatol. 2020 Feb;18(2):468-476.e11. doi: 10.1016/j.cgh.2019.07.047. Epub 2019 Jul 31.
Related trials for Hepatitis C, Chronic
RecruitingObservational study
Evaluation of Patients With Liver Disease
Hepatitis D, Hepatitis C
Active, not recruitingPhase 4
People With CHC Who Achieved a Sustained Virological Response Following Therapy With Direct Acting Antiviral Agents
Diabetes Mellitus, Hepatitis C, Chronic
RecruitingObservational study
"Constitution of a Biological Collection to Establish Preclinical Translational Models for the Study of Tumors and Chronic Liver Diseases".
Chronic Liver Disease and Cirrhosis, Liver Cancer
Active, not recruitingPhase 4
Sofosbuvir/Velpatasvir Treatment of Chronic Hepatitis C During Pregnancy
Hepatitis C, Chronic, Pregnancy; Infection
Enrolling by invitationObservational study
Comparative Autoantibody and Immunologic Cell Marker Study
Autoimmune Diseases, Lupus Erythematosus, Systemic
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Gilead Study Director study director
Gilead Sciences
325 sites in 17 countries: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Hepatitis C, Chronic, run by Gilead Sciences at 325 sites in 17 countries.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 4 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 31 Aug 2018. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 325 sites in United States, Australia, France, Germany, Italy and 12 more countries. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Proportion of participants maintaining SVR at Week 144 by treatment regimen (time frame: Week 144). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT01457755, which also lists 1 linked publication.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 31 Aug 2018.